Tech Company Financing Transactions
LeukoDx Funding Round
Axcel Partners participated in a $7 million capital raise for LeukoDx. The funding round closed on 6/16/2014.
Transaction Overview
Company Name
Announced On
6/16/2014
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Having secured this major cash infusion, we will now accelerate our plans to bring the Accellix platform and rapid sepsis test to market.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 HaMarpe St. 3rd Floor AVX Building
Har Hotzvim Jerusalem, 9777403
Israel
Har Hotzvim Jerusalem, 9777403
Israel
Phone
Website
Email Address
Overview
LeukoDx is an early-stage company advancing its novel compact fluorocytometry technology platform. The platform development was initiated at Caltech with NASA funding. This groundbreaking technology has a wide range of applications, from early Sepsis detection, to HIV/AIDS monitoring and beyond.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Julien Meissonnier
Chief Technical Officer
Harvey Kasdan
VP - Bus. Development
Allon Reiter
VP - Engineering
Micha Rosen
VP - Operations
Zion Botesazan
VP - R & D
Ephraim Carlebach
VP - Regulatory Affairs
Yael Himmel
Browse more venture capital transactions:
Prev: 6/16/2014: Romark Laboratories venture capital transaction
Next: 6/16/2014: Wisegate venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs